Back to mobile site

JPMorgan Reiterates Overweight Rating on Phibro Animal Health Corp. (PAHC) Ahead of Q4 Print

August 25, 2026 8:35 AM EDT Send to a Friend
JPMorgan analyst Ekaterina Knyazkova reiterated an Overweight rating and $58.00 price target on Phibro Animal Health Corp. (NASDAQ: PAHC).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login